GB9826178D0 - Novel process - Google Patents

Novel process

Info

Publication number
GB9826178D0
GB9826178D0 GBGB9826178.7A GB9826178A GB9826178D0 GB 9826178 D0 GB9826178 D0 GB 9826178D0 GB 9826178 A GB9826178 A GB 9826178A GB 9826178 D0 GB9826178 D0 GB 9826178D0
Authority
GB
United Kingdom
Prior art keywords
novel process
novel
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB9826178.7A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Ltd
Original Assignee
SmithKline Beecham Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Ltd filed Critical SmithKline Beecham Ltd
Priority to GBGB9826178.7A priority Critical patent/GB9826178D0/en
Publication of GB9826178D0 publication Critical patent/GB9826178D0/en
Priority to EP99973028A priority patent/EP1155016A1/en
Priority to PCT/GB1999/003996 priority patent/WO2000032595A1/en
Priority to AU13981/00A priority patent/AU1398100A/en
Priority to JP2000585237A priority patent/JP2002531453A/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/451—Non condensed piperidines, e.g. piperocaine having a carbocyclic group directly attached to the heterocyclic ring, e.g. glutethimide, meperidine, loperamide, phencyclidine, piminodine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
GBGB9826178.7A 1998-11-30 1998-11-30 Novel process Ceased GB9826178D0 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
GBGB9826178.7A GB9826178D0 (en) 1998-11-30 1998-11-30 Novel process
EP99973028A EP1155016A1 (en) 1998-11-30 1999-11-30 Process for the production of paroxetine hydrochloride acetone solvate
PCT/GB1999/003996 WO2000032595A1 (en) 1998-11-30 1999-11-30 Process for the production of paroxetine hydrochloride acetone solvate
AU13981/00A AU1398100A (en) 1998-11-30 1999-11-30 Process for the production of paroxetine hydrochloride acetone solvate
JP2000585237A JP2002531453A (en) 1998-11-30 1999-11-30 Preparation of paroxetine hydrochloride acetone solvate

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9826178.7A GB9826178D0 (en) 1998-11-30 1998-11-30 Novel process

Publications (1)

Publication Number Publication Date
GB9826178D0 true GB9826178D0 (en) 1999-01-20

Family

ID=10843290

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9826178.7A Ceased GB9826178D0 (en) 1998-11-30 1998-11-30 Novel process

Country Status (5)

Country Link
EP (1) EP1155016A1 (en)
JP (1) JP2002531453A (en)
AU (1) AU1398100A (en)
GB (1) GB9826178D0 (en)
WO (1) WO2000032595A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9923439D0 (en) * 1999-10-04 1999-12-08 Smithkline Beecham Plc Novel process
GB9923445D0 (en) * 1999-10-04 1999-12-08 Smithkline Beecham Plc Novel process

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1422263A (en) * 1973-01-30 1976-01-21 Ferrosan As 4-phenyl-piperidine compounds
GB8430581D0 (en) * 1984-12-04 1985-01-09 Ferrosan As Treatment
DE3688827T2 (en) * 1985-10-25 1994-03-31 Beecham Group Plc Piperidine derivative, its manufacture and its use as a medicine.
SK283608B6 (en) * 1995-02-06 2003-10-07 Smithkline Beecham Plc New forms of parotexin hydrochloride
EP1384720A1 (en) * 1996-06-13 2004-01-28 SUMIKA FINE CHEMICALS Co., Ltd. Process for drying paroxetine hydrochloride
HU221921B1 (en) * 1996-07-08 2003-02-28 Richter Gedeon Vegyészeti Gyár Rt. N-benzyl-piperidine or tetrahydro-pyridine derivatives and processes for producing them

Also Published As

Publication number Publication date
EP1155016A1 (en) 2001-11-21
JP2002531453A (en) 2002-09-24
WO2000032595A1 (en) 2000-06-08
AU1398100A (en) 2000-06-19

Similar Documents

Publication Publication Date Title
GB0106312D0 (en) Process
GB9816385D0 (en) Process
EP1127060A4 (en) Hydroboronation process
GB9827387D0 (en) Novel process
GB9826180D0 (en) Novel process
GB9826242D0 (en) Novel process
GB9816564D0 (en) Process
GB9806527D0 (en) Process
GB9826175D0 (en) Novel process
GB9824298D0 (en) Novel process
GB9817195D0 (en) Novel process
GB9826178D0 (en) Novel process
GB9828780D0 (en) Novel process
GB9828767D0 (en) Novel process
GB9828779D0 (en) Novel process
GB9806786D0 (en) Novel process
GB9807834D0 (en) Novel process
GB9812016D0 (en) Novel process
GB9826182D0 (en) Novel process
GB9813269D0 (en) Novel process
GB9817196D0 (en) Novel process
GB9828781D0 (en) Novel process
GB9817159D0 (en) Novel process
GB9816027D0 (en) Novel process
GB9805579D0 (en) Novel process

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)